PDGF mediates TGFβ-induced migration during development of the spinous process

Developmental Biology

Volumn 365, Issue 1, 2012, Pages 110-117

  Wang, Ying ^a   Serra, Rosa ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Axial skeleton; Migration; PDGF; Sclerotome; TGF type II receptor; Vertebrae

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARTILAGE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MESENCHYME; MESENCHYME CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; SCLEROTOME; VERTEBRA;

MUS;

EID: 84862780364     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.02.013     Document Type: Article

References (34)

1. Aase K., Abramsson A., Karlsson L., Betsholtz C., Eriksson U. Expression analysis of PDGF-C in adult and developing mouse tissues. Mech. Dev. 2002, 110:187-191.
2. Baffi M.O., Moran M.A., Serra R. Tgfbr2 regulates the maintenance of boundaries in the axial skeleton. Dev. Biol. 2006, 296:363-374.
3. Baffi M.O., Slattery E., Sohn P., Moses H.L., Chytil A., Serra R. Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones. Dev. Biol. 2004, 276:124-142.
4. Barrientos S., Stojadinovic O., Golinko M.S., Brem H., Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16:585-601.
5. Bornfeldt K.E., Raines E.W., Graves L.M., Skinner M.P., Krebs E.G., Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann. N. Y. Acad. Sci. 1995, 766:416-430.
6. Chai Y., Jiang X., Ito Y., Bringas P., Han J., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 2000, 127:1671-1679.
7. Christ B., Huang R., Wilting J. The development of the avian vertebral column. Anat. Embryol. (Berl) 2000, 202:179-194.
8. Chytil A., Magnuson M.A., Wright C.V., Moses H.L. Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis 2002, 32:73-75.
9. Ding H., Wu X., Bostrom H., Kim I., Wong N., Tsoi B., O'Rourke M., Koh G.Y., Soriano P., Betsholtz C., Hart T.C., Marazita M.L., Field L.L., Tam P.P., Nagy A. A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling. Nat. Genet. 2004, 36:1111-1116.
10. Furumoto T.A., Miura N., Akasaka T., Mizutani-Koseki Y., Sudo H., Fukuda K., Maekawa M., Yuasa S., Fu Y., Moriya H., Taniguchi M., Imai K., Dahl E., Balling R., Pavlova M., Gossler A., Koseki H. Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development. Dev. Biol. 1999, 210:15-29.
11. Haberstroh U., Zahner G., Disser M., Thaiss F., Wolf G., Stahl R.A. TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression. Am. J. Physiol. 1993, 264:F199-F205.
12. Heldin C.H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 1999, 79:1283-1316.
13. Janssens K., ten Dijke P., Janssens S., Van Hul W. Transforming growth factor-beta1 to the bone. Endocr. Rev. 2005, 26:743-774.
14. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994, 8:133-146.
15. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994, 8:1875-1887.
16. Molloy T., Wang Y., Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003, 33:381-394.
17. Monsoro-Burq A.H., Duprez D., Watanabe Y., Bontoux M., Vincent C., Brickell P., Le Douarin N. The role of bone morphogenetic proteins in vertebral development. Development 1996, 122:3607-3616.
18. Ovchinnikov D.A., Deng J.M., Ogunrinu G., Behringer R.R. Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice. Genesis 2000, 26:145-146.
19. Paaske P.B., Witten J., Schwer S., Hansen H.S. Results in treatment of carcinoma of the external auditory canal and middle ear. Cancer 1987, 59:156-160.
20. Payne J., Shibasaki F., Mercola M. Spina bifida occulta in homozygous Patch mouse embryos. Dev. Dyn. 1997, 209:105-116.
21. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30:e36.
22. Pickett E.A., Olsen G.S., Tallquist M.D. Disruption of PDGFRalpha-initiated PI3K activation and migration of somite derivatives leads to spina bifida. Development 2008, 135:589-598.
23. Pourquie O., Coltey M., Teillet M.A., Ordahl C., Le Douarin N.M. Control of dorsoventral patterning of somitic derivatives by notochord and floor plate. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5242-5246.
24. Reiterer G., Bunaciu R.P., Smith J.L., Yen A. Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells. FEBS Lett. 2008, 582:2508-2514.
25. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
26. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
27. Schmidt M.B., Chen E.H., Lynch S.E. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 2006, 14:403-412.
28. Serra R., Chang C. TGF-beta signaling in human skeletal and patterning disorders. Birth Defects Res. C Embryo Today 2003, 69:333-351.
29. Sohn P., Cox M., Chen D., Serra R. Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc. BMC Dev. Biol. 2010, 10:29.
30. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 1999, 21:70-71.
31. Stottmann R.W., Berrong M., Matta K., Choi M., Klingensmith J. The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms. Dev. Biol. 2006, 295:647-663.
32. Sun J., Wang D.A., Jain R.K., Carie A., Paquette S., Ennis E., Blaskovich M.A., Baldini L., Coppola D., Hamilton A.D., Sebti S.M. Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors. Oncogene 2005, 24:4701-4709.
33. Taylor L.M., Khachigian L.M. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads. J. Biol. Chem. 2000, 275:16709-16716.
34. Trojanowska M. Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 2008, 47(Suppl 5):v2-v4.